Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19. (2022)

Record Type:: Journal Article
Title:: Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19. (2022)
Main Title:: Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19
Authors:: Spiers, H.V.
Liau, S.-S.
Abstract:
Is Part Of:: HPB. Volume 24(2022)Supplement 1
Journal:: HPB
Issue:: Volume 24(2022)Supplement 1
Issue Display:: Volume 24, Issue 1 (2022)
Year:: 2022
Volume:: 24
Issue:: 1
Issue Sort Value:: 2022-0024-0001-0000
Page Start:: S343
Page End:
Publication Date:: 2022
Subjects:: Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005
Journal URLs:: https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1016/j.hpb.2022.05.727 ↗
Languages:: English
ISSNs:: 1365-182X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24090.xml